Show an ad over header. AMP

Gov. Gavin Newsom says California will independently review FDA-approved coronavirus vaccines

California will "independently review" all coronavirus vaccines approved by the federal Food and Drug Administration for distribution, Gov. Gavin Newsom (D) announced at a news conference Monday.

Why it matters: The move that comes days after NAID director Anthony Fauci said he had "strong confidence" in FDA-approved vaccines could cast further public doubt that the federal government could release a vaccine based on political motives, rather than safety and efficacy.


Of note: Newsom said he considers mid-2021 to be a realistic projection for when a vaccine could be publicly distributed, noting the "political polarization" around the issue.

  • "No matter who the next president is, we're going to maintain our vigilance," he added.

What else he's saying: "Of course, we don’t take anyone's word for it," Newsom said, announcing the establishment of the Scientific Safety Review Workgroup.

  • "We will do our own independently reviewed process with our world-class experts.
  • "These experts … will independently review and monitor any vaccine trials to guarantee safety, to guarantee equity and to guarantee the transparency of the distribution of our vaccines."

The big picture: Faucitold CBS Evening News last week that scientists should know by November or December whether potential COVID-19 vaccines are safe and effective and that vaccine candidates undergoing clinical trials could be widely available by April if this is proven to be the case.

  • Health officials testified on Capitol Hill in September that the vaccine approval process would be based on safety and efficacy, not politics.
  • The FDA also stressed in new guidelines last month it would toughen the requirements for a coronavirus vaccine emergency authorization.
  • The FDA did not immediately respond to Axios' request for comment.

How institutions that control vast wealth fall through U.S. regulatory cracks

Financial regulation is not exactly simple anywhere in the world. But one country stands out for the sheer amount of complexity and confusion in its regulatory regime — the U.S.

Why it matters: Important companies fall through the cracks, largely unregulated, while others contend with a vast array of regulatory bodies, none of which are remotely predictable.

Keep reading... Show less

Trump nominee Christopher Waller confirmed to Fed board

The Senate voted 48-47 on Thursday to confirm Trump nominee Christopher Waller to the Federal Reserve Board of Governors — filling one of the two vacant slots on the influential economic body.

Why it matters: It's one of the last marks left on the Fed board by Trump, who has nominated five of its six members.

Keep reading... Show less

Boeing gets huge 737 Max order from Ryanair, boosting hope for quick rebound

Dublin-based Ryanair said it would add 75 more planes to an existing order for Boeing's 737 Max airplanes, a giant vote of confidence as Boeing seeks to revive sales of its best-selling plane after a 20-month safety ban following two fatal crashes.

The big picture: Ryanair's big order, on the heels of breakthrough vaccine news, is also a promising sign that the devastated airline industry might recover from the global pandemic sooner than expected.

Keep reading... Show less

Trump sets auction for Arctic refuge drilling rights before Biden takes office

The Interior Department on Thursday said it will auction oil drilling leases in Alaska's Arctic National Wildlife Refuge in early January.

Why it matters: The procedural step would make it harder for President-elect Joe Biden to thwart drilling in the region, even though any actual development is years away.

Keep reading... Show less

Rep. Sean Patrick Maloney elected chair of House Democrats' campaign arm

Rep. Sean Patrick Maloney (D-N.Y.) on Thursday was elected chair of the Democratic Congressional Campaign Committee for the 2022 cycle, narrowly defeating Rep. Tony Cardenas (D-Calif.) 119 to 107, Politico reports.

Why it matters: Maloney will be tasked with protecting House Democrats' slim majority in 2022 after they underperformed in November's election, losing seats in down-ballot races across the country.

Keep reading... Show less

Vaccine shipment companies targeted by cyberattacks, IBM says

A global phishing campaign has been trying to gain information from organizations working to ship coronavirus vaccines since September, IBM's cybersecurity arm said on Thursday.

Why it matters: Successfully distributing a COVID vaccine will already be challenging for the U.S. and other wealthy countries, especially to rural areas with less resources — while poorer countries are expected to have delayed access.

Keep reading... Show less

Fauci to meet with Biden transition for first time

The government's top infectious-disease expert Anthony Fauci will stay on at the National Institutes of Health and plans to meet virtually with President-elect Joe Biden's transition team to discuss the coronavirus response for the first time Thursday, he told CBS News.

Why it matters: Fauci, widely viewed as one of the country's most trusted voices on the coronavirus, said it will be the first "substantive" conversation between he and Biden's team. He said he has not yet spoken with Biden directly, but has connected several times with incoming White House Chief of Staff Ron Klain.

Keep reading... Show less

Trump weighs firing Barr over fraud comments and Durham delay

Attorney General Barr may be fired or resign, as President Trump seethes about Barr's statement this week that no widespread voter fraud has been found.

Behind the scenes: A source familiar with the president's thinking tells Axios that Trump remains frustrated with what he sees as the lack of a vigorous investigation into his election conspiracy theories.

Keep reading... Show less

Insights

mail-copy

Get Goodhumans in your inbox

Most Read

More Stories